Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$6.23 - $13.09 $12,565 - $26,402
-2,017 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$5.23 - $15.2 $235 - $684
-45 Reduced 2.18%
2,017 $14,000
Q4 2019

Feb 04, 2020

SELL
$12.58 - $15.97 $327 - $415
-26 Reduced 1.25%
2,062 $29,000
Q3 2019

Nov 12, 2019

BUY
$10.73 - $17.33 $22,404 - $36,185
2,088 New
2,088 $32,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $541M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.